中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2011年
4期
426-429
,共4页
胡学忠%梁小波%姜慧员%李超亿%马俊杰
鬍學忠%樑小波%薑慧員%李超億%馬俊傑
호학충%량소파%강혜원%리초억%마준걸
直肠癌%MSCT%真实性%可靠性
直腸癌%MSCT%真實性%可靠性
직장암%MSCT%진실성%가고성
Rectal carcinoma%MSCT%Validity%Reliability
目的 研究多层螺旋CT(MSCT)对直肠癌术前TNM分期的真实性、可靠性.方法 对2009年1-12月山西省肿瘤医院收治的301例直肠癌患者的临床资料进行回顾分析,比较术前MSCT分期与术后病理分期,采用Medcalc软件对结果进行ROC曲线分析及诊断一致性分析.结果 TNM分期的灵敏度、特异度、Kappa值、曲线下面积分别是:T2期为64.7%、96.8%、0.667、0.808;T3期为93.8%、75.0%、0.709、0.844;T4期为87.8%、98.1%、0.859、0.929;N分期为72.0%、91.2%、0.619、0.816;M分期为92.7%、99.7%、0.925、0.963.结论 MSCT对直肠癌浸润程度和淋巴结转移的评价有明显的局限性,不宜单独用于直肠癌术前分期的评估.
目的 研究多層螺鏇CT(MSCT)對直腸癌術前TNM分期的真實性、可靠性.方法 對2009年1-12月山西省腫瘤醫院收治的301例直腸癌患者的臨床資料進行迴顧分析,比較術前MSCT分期與術後病理分期,採用Medcalc軟件對結果進行ROC麯線分析及診斷一緻性分析.結果 TNM分期的靈敏度、特異度、Kappa值、麯線下麵積分彆是:T2期為64.7%、96.8%、0.667、0.808;T3期為93.8%、75.0%、0.709、0.844;T4期為87.8%、98.1%、0.859、0.929;N分期為72.0%、91.2%、0.619、0.816;M分期為92.7%、99.7%、0.925、0.963.結論 MSCT對直腸癌浸潤程度和淋巴結轉移的評價有明顯的跼限性,不宜單獨用于直腸癌術前分期的評估.
목적 연구다층라선CT(MSCT)대직장암술전TNM분기적진실성、가고성.방법 대2009년1-12월산서성종류의원수치적301례직장암환자적림상자료진행회고분석,비교술전MSCT분기여술후병리분기,채용Medcalc연건대결과진행ROC곡선분석급진단일치성분석.결과 TNM분기적령민도、특이도、Kappa치、곡선하면적분별시:T2기위64.7%、96.8%、0.667、0.808;T3기위93.8%、75.0%、0.709、0.844;T4기위87.8%、98.1%、0.859、0.929;N분기위72.0%、91.2%、0.619、0.816;M분기위92.7%、99.7%、0.925、0.963.결론 MSCT대직장암침윤정도화림파결전이적평개유명현적국한성,불의단독용우직장암술전분기적평고.
Objective To evaluate the validity and reliability of multi-slice spiral CT (MSCT) in preoperative TNM staging judgment of rectal carcinoma. Methods Three hundred and one patients with rectal carcinoma were diagnosed and treated consecutively in Colorectal and Anal Surgery Department of Shanxi Province Tumor Hospital from January 2009 to December 2009. The clinical data of these patients were analyzed retrospectively. The diagnosis results were compared between the preoperative MSCT staging and the postoperative pathological staging,the ROC curve and the diagnostic concordance test were analyzed by software Medcalc 11.2. Results The sensitivity, specificity, Kappa value, area under the curve of TNM staging were 64.7% ,96. 8% ,0. 667,0. 808 for T2 staging tumors; 93.8% ,75.0% ,0.709,0.844 for T3 staging tumors;87. 8% ,98. 1% ,0. 859,0. 929 for T4 staging tumors; 72. 0% ,91.2% ,0. 619,0. 816 for N staging tumors;92. 7%, 99. 7%, 0. 925,0. 963 for M staging tumors respectively. Conclusion The diagnostic value of independent use of MSCT in estimating the infiltration degree and lymph node metastasis of rectal cancer is very poor and cannot be used in preoperative staging judgment.